Institut Für Klinische Krebsforschung Ikf Gmbh At Krankenhaus Nordwest

This study tests a drug called bemarituzumab combined with different chemotherapies for people with advanced stomach or gastroesophageal junction cancer that has a specific marker (FGFR2b). Participants have already tried at least one chemotherapy that didn't work. The goal is to…

This study tests a three-drug combination (chemotherapy plus two targeted drugs) as a first treatment for people with advanced HER2-positive bile duct or gallbladder cancer that cannot be removed by surgery. The goal is to see how well the drugs shrink tumors and control the dise…

This study tests whether a combination of ramucirumab plus FOLFIRI can help people with advanced stomach or gastroesophageal junction cancer live longer compared to the current standard of ramucirumab plus paclitaxel. The trial includes 429 adults whose cancer progressed after on…

This early-stage trial tests an experimental drug called IMP321, which aims to boost the immune system's ability to fight cancer. It is given alongside standard treatments like chemotherapy or immunotherapy to people with advanced solid tumors that have spread. The main goal is t…